Literature DB >> 1691263

Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

M J Smyth1, J R Ortaldo, Y Shinkai, H Yagita, M Nakata, K Okumura, H A Young.   

Abstract

Our studies have analyzed pore-forming protein (PFP) mRNA expression in resting and stimulated human peripheral blood CD3- large granular lymphocytes (LGL), CD3+ T cells, and their CD4+ or CD8+ subsets. Signals that stimulate T cells to develop cytotoxic activity (i.e., IL-2 or OKT-3 mAb) led to the induction of PFP mRNA in T cells. The data indicated that IL-2 directly increased PFP mRNA in the CD8+ subset of T cells, in the absence of new DNA or protein synthesis. Abrogation of IL-2-induced PFP mRNA expression and cytotoxic potential of T cells by the anti-p75 IL-2 receptor mAb suggested that low numbers of p75 IL-2 receptors on CD8+ T cells were capable of transducing signals responsible for these IL-2-induced effects. The induction of T cell PFP mRNA via CD3, using OKT-3 mAb, was less rapid but greater than that caused by IL-2; however, a combination of PMA and ionomycin, which bypasses crosslinking of the TCR/CD3 complex, could not mimic this increase in PFP mRNA levels in T cells. The role of second messenger systems in regulating PFP mRNA expression remains to be determined. In contrast, high constitutive PFP mRNA expression was observed in CD3- LGL and these mRNA levels could not be enhanced by stimulation with IL-2. The cytotoxic potential of peripheral blood T cells and LGL induced in response to IL-2 correlated with IL-2-induced PFP mRNA levels in these cells and was consistent with PFP being one of several important molecules involved in the effector function of cytotoxic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691263      PMCID: PMC2187847          DOI: 10.1084/jem.171.4.1269

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.

Authors:  D K Ferris; J Willette-Brown; J R Ortaldo; W L Farrar
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

2.  Homology of perforin to the ninth component of complement (C9).

Authors:  Y Shinkai; K Takio; K Okumura
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

3.  Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.

Authors:  Y Shinkai; M C Yoshida; K Maeda; T Kobata; K Maruyama; J Yodoi; H Yagita; K Okumura
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Protein kinase C required for cytotoxic T lymphocyte triggering.

Authors:  T Nishimura; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

5.  Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.

Authors:  D E Martin; L S Zalman; G Jung; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2.

Authors:  E M Saltzman; R R Thom; J E Casnellie
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

7.  Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.

Authors:  A Granelli-Piperno; M Keane; R M Steinman
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

8.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Authors:  J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

9.  Activation of natural killer cells via the p75 interleukin 2 receptor.

Authors:  J H Phillips; T Takeshita; K Sugamura; L L Lanier
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

10.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  25 in total

1.  Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.

Authors:  E Berti; D Tomasini; M H Vermeer; C J Meijer; E Alessi; R Willemze
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

4.  Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV).

Authors:  Lesley White; Subramaniam Krishnan; Natasa Strbo; Huanliang Liu; Michael A Kolber; Mathias G Lichtenheld; Rajendra N Pahwa; Savita Pahwa
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

5.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

6.  Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.

Authors:  T Nakamura; I Ebihara; Y Tomino; K Okumura; H Koide
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cells.

Authors:  A Nakamura; S Sone; R Nabioullin; K Sugihara; M Munekata; Y Nishioka; A Nii; T Ogura
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.

Authors:  G Berke; D Rosen; D Ronen
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

9.  Characterization of a novel monoclonal antibody against human perforin using transfected cell lines.

Authors:  B C Schlesinger; L Cheng
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

10.  Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.

Authors:  A Hameed; K J Olsen; L Cheng; W M Fox; R H Hruban; E R Podack
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.